Botulinum toxin is the bread and butter of aesthetics, and year on year continues to be the most popular treatment in medical aesthetic clinics.1 All approved BoNT-A products (or formulations) in Europe come in powder form and require reconstitution with sodium chloride before use – until now. With continuing advancements in technology, this month sees the official launch of Alluzience at ACE 2023 – the first ever ready-to-use neuromodulator (ABont-A liquid toxin).
Produced by global pharmaceutical company Galderma, Alluzience is a liquid formulation that avoids any calculations to reconstitute the product from powder to liquid form.2 It is approved for treatment of moderate to severe glabellar lines.2
Aesthetic practitioner Dr Kuldeep Minocha, who was one of the first UK practitioners to use the toxin in the UK, comments, “Alluzience is a brand new abobotulinumtoxin that comes reconstituted…
